Who is sponsoring NCT04994600?

NCT04994600 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT04994600?

Interventions in NCT04994600: Reduces number of question items.

What condition does NCT04994600 study?

NCT04994600 studies Alarm Fatigue.

Is NCT04994600 still recruiting?

NCT04994600 is currently completed. Last updated 8 September 2023.

Last reviewed 2023-09-08 · How we verify

NCT04994600: alarmZen1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Design and Validation of a German Language Questionnaire for Measuring Alarm Fatigue in Intensive Care Units

Completed Last updated 8 September 2023

What this trial tests

trial testing Reduces number of question items in Alarm Fatigue in 700 participants. Completed in 1 September 2023.

Timeline

19 March 2021

Primary endpoint
1 September 2023

1 September 2023

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Status	Completed
Study type	OBSERVATIONAL
Enrollment	700
Start date	19 March 2021
Primary completion	1 September 2023
Estimated completion	1 September 2023
Sites	1 location across Germany

Drugs / interventions tested

Reduces number of question items

Conditions studied

Alarm Fatigue — all drugs for Alarm Fatigue →

Sponsor

Charite University, Berlin, Germany

Who can join

Eligibility, any sex, with Alarm Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

False-positive and non-actionable alarms can lead to staff desensitization ("alarm fatigue") and thus patient endangerment. With this study the investigators create a basic tool to survey alarm fatigue of intensive care staff: the first German language alarm fatigue questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alarm Fatigue

Currently open trials in the same condition.

NCT07364097 — A Study of Silent Alarm Delivery Versus Standard Audible Alarm Delivery in Intensive Care and High Dependency Units · NA · active not recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04994600 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 8 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing